Pharmacogenomics: a path to predictive medicine for schizophrenia.
about
Promise of personalized omics to precision medicineEvaluation of research topic evolution in psychiatry using co-word analysis.Pharmacogenetic treatments for drug addiction: cocaine, amphetamine and methamphetamine.Visualization analysis of author collaborations in schizophrenia research.Personal genomes, quantitative dynamic omics and personalized medicineAnalysis on evolution and research focus in psychiatry field.Exploring schizophrenia drug-gene interactions through molecular network and pathway modelingAddiction pharmacogenetics: a systematic review of the genetic variation of the dopaminergic systemGlobal pharmacogenetics: giving the genome to the masses.Analysis on international scientific collaboration and research focus on depression field.Medications Development for the Treatment of Nicotine Dependence in Individuals with Schizophrenia.Pharmacogenetic treatments for drug addiction: alcohol and opiates.Pharmacogenomics and treatment for dementia induced by Alzheimer's disease.Treatment of schizophrenia in the 21st Century: beyond the neurotransmitter hypothesis.The phe-124-Cys and A-161T variants of the human 5-HT1B receptor gene are not major determinants of the clinical response to sumatriptan.Early improvement on antipsychotic treatment as a predictor of subsequent response in schizophrenia: analyses from ziprasidone clinical studies.Association studies of catechol-O-methyltransferase (COMT) gene with schizophrenia and response to antipsychotic treatment.Genetic susceptibility to schizophrenia: role of dopaminergic pathway gene polymorphisms.Genetic epidemiology of pharmacogenetic variations in CYP2C9, CYP4F2 and VKORC1 genes associated with warfarin dosage in the Indian population.Investigation of possible association between Ser9Gly polymorphism of the D3 dopaminergic receptor gene and response to typical antipsychotics in patients with schizophrenia.
P2860
Q26852592-559592CD-2E8F-41F1-B4A9-F926EFA0A6DEQ33833915-2DC91774-6172-4D01-95DD-D3A87B81B5C2Q34982551-0A67C180-1AD5-414A-A16A-F55763F6653AQ35120826-AFFAF7E2-F02C-487B-AAC1-957CCB6A6D8EQ35195408-30E0EB74-FCD5-4927-B7AF-9AEC31B95295Q35623530-EA59D253-E665-475F-BEE7-DDB1F2296CAFQ35624956-27B9E02B-C890-49E3-8571-549DF844E929Q35995415-E73DF005-52BE-442E-AE15-0BC496C9CDB1Q36497092-CA286ED7-96D3-43D4-8710-50AA9027DAB4Q36807191-7278E0B0-2916-47A5-8F4C-CF81FE2D85A2Q37079797-1FE0569A-002A-47C0-B66A-F8F2A7DD98FDQ37201611-F20D2696-60FD-40F2-AB9A-A3F1CBA67A1EQ37205951-A1BDA9C8-FF8F-4126-BD9C-491E5D000239Q37356489-21C5F04C-B63F-4737-BE69-E106D917E48CQ39335472-F53EE779-C3C9-49D9-9C0E-5F82BBF9D84DQ43989313-43AE9487-7EB9-4C68-B125-CC6DAFAFE1F7Q46086323-9ACDC4C1-7743-4EE3-A091-573977889250Q46126668-6179F763-B42E-40D9-9B06-05CB580D1629Q46239544-9F2F52FD-0F69-4135-836C-7BBD523471E1Q54570430-54C276E3-E6EE-4E31-B474-F55C0318502C
P2860
Pharmacogenomics: a path to predictive medicine for schizophrenia.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Pharmacogenomics: a path to predictive medicine for schizophrenia.
@ast
Pharmacogenomics: a path to predictive medicine for schizophrenia.
@en
type
label
Pharmacogenomics: a path to predictive medicine for schizophrenia.
@ast
Pharmacogenomics: a path to predictive medicine for schizophrenia.
@en
prefLabel
Pharmacogenomics: a path to predictive medicine for schizophrenia.
@ast
Pharmacogenomics: a path to predictive medicine for schizophrenia.
@en
P2093
P2860
P356
P1433
P1476
Pharmacogenomics: a path to predictive medicine for schizophrenia.
@en
P2093
Samir K Brahmachari
Sanjeev Jain
Simone Gupta
P2860
P356
10.2217/14622416.7.1.31
P577
2006-01-01T00:00:00Z